Keeping up with corporate filings shouldn't be a full-time job.

Lack of time and motivation to wade through dense documents means missing out on portfolio-boosting opportunities.

Stay informed, invest smarter: AI-powered corporate filing summaries.

Setup Free Alerts → Browse Latest Filings
Sign up to stay up to date with the stocks you care about

Most recent public disclosures: AI-powered summaries of the latest corporate filings

1451
1
MIRA PHARMACEUTICALS, INC. Mira Pharmaceuticals Reports Financial Changes, Net Loss Improvement, and Focus on Lead Compounds

Via official filing (AI summary) | 11 days ago | 0 comments

1452
1
BP PRUDHOE BAY ROYALTY TRUST BP Prudhoe Bay Royalty Trust Reports Significant Declines in Cash Earnings and Assets

Via official filing (AI summary) | 11 days ago | 0 comments

1453
1
Telomir Pharmaceuticals, Inc. Telomir Pharmaceuticals Reports Significant Financial Changes, Net Loss, and Doubt Over Going Concern in 10-Q Filing

Via official filing (AI summary) | 11 days ago | 0 comments

1454
1
Longeveron Inc. Longeveron Reports 415% Revenue Growth, Net Loss Reduction in Q3 2024

Via official filing (AI summary) | 11 days ago | 0 comments

1455
1
SAGA COMMUNICATIONS INC SAGA Communications Reports Decline in Revenue and Profitability for Q3 and Nine Months Ended September 30, 2024

Via official filing (AI summary) | 11 days ago | 0 comments

1456
1
FIRST COMMONWEALTH FINANCIAL CORP /PA/ First Commonwealth Financial Corporation Reports Mixed Q3 and 9M Results, with Asset Growth and Increased Retained Earnings

Via official filing (AI summary) | 11 days ago | 0 comments

1457
1
PREMIER FINANCIAL CORP Premier Financial Corp. Reports Decline in Net Income and Net Interest Income in Q3 2024

Via official filing (AI summary) | 11 days ago | 0 comments

1458
1
Acurx Pharmaceuticals, Inc. Acurx Pharmaceuticals Reports Financial Results, Raises Funds Amid Ongoing Clinical Development of Ibezapolstat

Via official filing (AI summary) | 11 days ago | 0 comments

1459
1
MEI Pharma, Inc. MEI Pharma Reports Significant Financial Challenges, Net Loss, and Halted Clinical Trials in Q3 2024

Via official filing (AI summary) | 11 days ago | 0 comments

1460
1
FIDELITY D & D BANCORP INC Fidelity D & D Bancorp Reports Mixed Financial Results for Q3 and Nine Months Ended September 30, 2024

Via official filing (AI summary) | 11 days ago | 0 comments

1461
1
BERKSHIRE HILLS BANCORP INC Berkshire Hills Bancorp Reports 3Q 2024 Financial Results, Net Income Up 92% Year-Over-Year

Via official filing (AI summary) | 11 days ago | 0 comments

1462
1
IGC Pharma, Inc. IGC Pharma Reports 42% Revenue Growth, Improved Profitability, and Advancements in Clinical Pipeline

Via official filing (AI summary) | 11 days ago | 0 comments

1463
1
TRIUMPH GROUP INC Triumph Group Reports Improved Revenue and Profitability in Q2 2024

Via official filing (AI summary) | 11 days ago | 0 comments

1464
1
OPAL Fuels Inc. OPAL Fuels Reports 18.2% Revenue Growth, Net Income Increase in Q3 2024

Via official filing (AI summary) | 11 days ago | 0 comments

1465
1
Valkyrie Bitcoin Fund CoinShares Valkyrie Bitcoin Fund Reports $569.8M in Assets, 2.39% Total Return at NAV

Via official filing (AI summary) | 11 days ago | 0 comments

1466
1
First Guaranty Bancshares, Inc. First Guaranty Bancshares Reports 10.4% Asset Growth, 44.5% Net Income Increase in Q3 2024

Via official filing (AI summary) | 11 days ago | 0 comments

1467
1
Corvus Pharmaceuticals, Inc. Corvus Pharmaceuticals Reports Significant Financial Changes, Net Loss Increases to $40.2 Million in Q3 2024

Via official filing (AI summary) | 11 days ago | 0 comments

1468
1
FATE THERAPEUTICS INC Fate Therapeutics Reports Q3 2024 Financial Results, Collaboration Revenue Decreases Due to Janssen Biotech Termination

Via official filing (AI summary) | 11 days ago | 0 comments

1469
1
TechTarget Inc TechTarget Reports Mixed Q3 Results, Net Loss, and Increased Cash Reserves Ahead of Informa Merger

Via official filing (AI summary) | 11 days ago | 0 comments

1470
1
AgeX Therapeutics, Inc. Serina Therapeutics Reports Mixed Financial Results, Raises Concerns Over Going Concern

Via official filing (AI summary) | 11 days ago | 0 comments

1471
1
PROKIDNEY CORP. ProKidney Corp. Reports Financial Results, Cash and Cash Equivalents Increase to $108.1 Million

Via official filing (AI summary) | 11 days ago | 0 comments

1472
1
SANGAMO THERAPEUTICS, INC Sangamo Therapeutics Reports Mixed Financial Results, Seeks Additional Capital Amid Restructuring Efforts

Via official filing (AI summary) | 11 days ago | 0 comments

1473
1
UNITED STATES ANTIMONY CORP United States Antimony Corporation Reports Revenue Growth, Net Loss in Q3 2024

Via official filing (AI summary) | 11 days ago | 0 comments

1474
1
KOPIN CORP Kopin Corporation Reports Revenue Growth, Net Loss, and Increased Liabilities in Latest Quarter

Via official filing (AI summary) | 11 days ago | 0 comments

1475
1
Sanara MedTech Inc. Sanara MedTech Reports 35% Revenue Growth, Increased Debt, and Net Loss in Latest Quarter

Via official filing (AI summary) | 11 days ago | 0 comments